1. Brodalumab in patients who had inadequate response to ustekinumab. (1st February 2019) Authors: Langley, R.G.; Armstrongi, A.W.; Lebwohl, M.G.; Blauvelt, A.; Hsu, S.; Tyring, S.; Rastogi, S.; Pillai, R.; Israel, R. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: e40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brodalumab in patients who had inadequate response to ustekinumab. (4th February 2019) Authors: Langley, R.G.; Armstrongi, A.W.; Lebwohl, M.G.; Blauvelt, A.; Hsu, S.; Tyring, S.; Rastogi, S.; Pillai, R.; Israel, R. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: e40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brodalumab 用于对乌司奴单抗应答不足的患者. (1st February 2019) Authors: Langley, R.G.; Armstrongi, A.W.; Lebwohl, M.G.; Blauvelt, A.; Hsu, S.; Tyring, S.; Rastogi, S.; Pillai, R.; Israel, R. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: e53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Brodalumab 用于对乌司奴单抗应答不足的患者. (4th February 2019) Authors: Langley, R.G.; Armstrongi, A.W.; Lebwohl, M.G.; Blauvelt, A.; Hsu, S.; Tyring, S.; Rastogi, S.; Pillai, R.; Israel, R. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: e53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials. (1st February 2019) Authors: Langley, R.G.; Armstrong, A.W.; Lebwohl, M.G.; Blauvelt, A.; Hsu, S.; Tyring, S.; Rastogi, S.; Pillai, R.; Israel, R. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials. (27th December 2018) Authors: Langley, R.G.; Armstrong, A.W.; Lebwohl, M.G.; Blauvelt, A.; Hsu, S.; Tyring, S.; Rastogi, S.; Pillai, R.; Israel, R. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials. (30th March 2018) Authors: Gottlieb, A.B.; Gordon, K.; Hsu, S.; Elewski, B.; Eichenfield, L.F.; Kircik, L.; Rastogi, S.; Pillai, R.; Israel, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 8(2018) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗